Table 1 Summary of the number of patients included in each genetic subtype, the age range, and the number and percentage of patients with cystoid macular oedema (CMO) in each group

Genetic type	Patients included (n)	Age range (years)	Patients with CMO in both eyes	Patients with CMO in at least one eye
Genetic type	Patients included (n)	Age range (years)	n (%)	n (%)
AD	31	12–71	12 (39)	16 (52)
AR	18	12–67	4 (22)	7 (39)
Isolated	39	8–67	11 (28)	15 (39)
X linked	9	9–65	0 (0)	0 (0)
Usher II	23	9–53	6 (26)	8 (35)
Unknown	4	14–52	1 (25)	1 (25)
Total	124	8–71	34 (27)	47 (38)

AD, autosomal dominant; AR, autosomal recessive.